SEC Form 4 · accession 0001250086-26-000002
Lexeo Therapeutics, Inc. · LXEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reinaldo M Diaz
Director
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001907108
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.70 | Jun 25, 2026 | A | 35,000 | A | — | Jun 24, 2036 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date.